カテゴリー： 世界, 医療/バイオ, QYResearch

ニフェジピン薬の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Nifedipine Medication Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10428）・商品コード：QY22JLX10428
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：72
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、ニフェジピン薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にニフェジピン薬の世界市場のxxx％を占める「カプセル」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「狭心症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ニフェジピン薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのニフェジピン薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ニフェジピン薬のグローバル主要企業には、Elite Pharmaceutical Solution Inc.、Pharmaoffer.com、Mylanなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ニフェジピン薬市場は、種類と用途によって区分されます。世界のニフェジピン薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
カプセル、錠剤

【用途別セグメント】
狭心症、高血圧、レイノー現象、早産

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ニフェジピン薬製品概要
- 種類別市場（カプセル、錠剤）
- 用途別市場（狭心症、高血圧、レイノー現象、早産）
- 調査の目的
・エグゼクティブサマリー
- 世界のニフェジピン薬販売量予測2017-2028
- 世界のニフェジピン薬売上予測2017-2028
- ニフェジピン薬の地域別販売量
- ニフェジピン薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ニフェジピン薬販売量
- 主要メーカー別ニフェジピン薬売上
- 主要メーカー別ニフェジピン薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（カプセル、錠剤）
- ニフェジピン薬の種類別販売量
- ニフェジピン薬の種類別売上
- ニフェジピン薬の種類別価格
・用途別市場規模（狭心症、高血圧、レイノー現象、早産）
- ニフェジピン薬の用途別販売量
- ニフェジピン薬の用途別売上
- ニフェジピン薬の用途別価格
・北米市場
- 北米のニフェジピン薬市場規模（種類別、用途別）
- 主要国別のニフェジピン薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのニフェジピン薬市場規模（種類別、用途別）
- 主要国別のニフェジピン薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のニフェジピン薬市場規模（種類別、用途別）
- 主要国別のニフェジピン薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のニフェジピン薬市場規模（種類別、用途別）
- 主要国別のニフェジピン薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのニフェジピン薬市場規模（種類別、用途別）
- 主要国別のニフェジピン薬市場規模（トルコ、サウジアラビア）
・企業情報
Elite Pharmaceutical Solution Inc.、Pharmaoffer.com、Mylan
・産業チェーン及び販売チャネル分析
- ニフェジピン薬の産業チェーン分析
- ニフェジピン薬の原材料
- ニフェジピン薬の生産プロセス
- ニフェジピン薬の販売及びマーケティング
- ニフェジピン薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ニフェジピン薬の産業動向
- ニフェジピン薬のマーケットドライバー
- ニフェジピン薬の課題
- ニフェジピン薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Nifedipine Medication Market
Due to the COVID-19 pandemic, the global Nifedipine Medication market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Capsule accounting for % of the Nifedipine Medication global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Angina segment is altered to an % CAGR throughout this forecast period.
China Nifedipine Medication market size is valued at US$ million in 2021, while the US and Europe Nifedipine Medication are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nifedipine Medication landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Nifedipine Medication include Elite Pharmaceutical Solution Inc., Pharmaoffer.com and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Nifedipine Medication Scope and Segment
Nifedipine Medication market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nifedipine Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Capsule
Tablet
Segment by Application
Angina
High Blood Pressure
Raynaud’s phenomenon
Premature Labor
By Company
Elite Pharmaceutical Solution Inc.
Pharmaoffer.com
Mylan
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Nifedipine Medication Product Introduction
1.2 Market by Type
1.2.1 Global Nifedipine Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Tablet
1.3 Market by Application
1.3.1 Global Nifedipine Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Angina
1.3.3 High Blood Pressure
1.3.4 Raynaud’s phenomenon
1.3.5 Premature Labor
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nifedipine Medication Sales Estimates and Forecasts 2017-2028
2.2 Global Nifedipine Medication Revenue Estimates and Forecasts 2017-2028
2.3 Global Nifedipine Medication Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nifedipine Medication Sales by Region
2.4.1 Global Nifedipine Medication Sales by Region (2017-2022)
2.4.2 Global Sales Nifedipine Medication by Region (2023-2028)
2.5 Global Nifedipine Medication Revenue by Region
2.5.1 Global Nifedipine Medication Revenue by Region (2017-2022)
2.5.2 Global Nifedipine Medication Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nifedipine Medication Sales by Manufacturers
3.1.1 Global Top Nifedipine Medication Manufacturers by Sales (2017-2022)
3.1.2 Global Nifedipine Medication Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nifedipine Medication in 2021
3.2 Global Nifedipine Medication Revenue by Manufacturers
3.2.1 Global Nifedipine Medication Revenue by Manufacturers (2017-2022)
3.2.2 Global Nifedipine Medication Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nifedipine Medication Revenue in 2021
3.3 Global Nifedipine Medication Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nifedipine Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nifedipine Medication Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nifedipine Medication Sales by Type
4.1.1 Global Nifedipine Medication Historical Sales by Type (2017-2022)
4.1.2 Global Nifedipine Medication Forecasted Sales by Type (2023-2028)
4.1.3 Global Nifedipine Medication Sales Market Share by Type (2017-2028)
4.2 Global Nifedipine Medication Revenue by Type
4.2.1 Global Nifedipine Medication Historical Revenue by Type (2017-2022)
4.2.2 Global Nifedipine Medication Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nifedipine Medication Revenue Market Share by Type (2017-2028)
4.3 Global Nifedipine Medication Price by Type
4.3.1 Global Nifedipine Medication Price by Type (2017-2022)
4.3.2 Global Nifedipine Medication Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nifedipine Medication Sales by Application
5.1.1 Global Nifedipine Medication Historical Sales by Application (2017-2022)
5.1.2 Global Nifedipine Medication Forecasted Sales by Application (2023-2028)
5.1.3 Global Nifedipine Medication Sales Market Share by Application (2017-2028)
5.2 Global Nifedipine Medication Revenue by Application
5.2.1 Global Nifedipine Medication Historical Revenue by Application (2017-2022)
5.2.2 Global Nifedipine Medication Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nifedipine Medication Revenue Market Share by Application (2017-2028)
5.3 Global Nifedipine Medication Price by Application
5.3.1 Global Nifedipine Medication Price by Application (2017-2022)
5.3.2 Global Nifedipine Medication Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nifedipine Medication Market Size by Type
6.1.1 North America Nifedipine Medication Sales by Type (2017-2028)
6.1.2 North America Nifedipine Medication Revenue by Type (2017-2028)
6.2 North America Nifedipine Medication Market Size by Application
6.2.1 North America Nifedipine Medication Sales by Application (2017-2028)
6.2.2 North America Nifedipine Medication Revenue by Application (2017-2028)
6.3 North America Nifedipine Medication Market Size by Country
6.3.1 North America Nifedipine Medication Sales by Country (2017-2028)
6.3.2 North America Nifedipine Medication Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Nifedipine Medication Market Size by Type
7.1.1 Europe Nifedipine Medication Sales by Type (2017-2028)
7.1.2 Europe Nifedipine Medication Revenue by Type (2017-2028)
7.2 Europe Nifedipine Medication Market Size by Application
7.2.1 Europe Nifedipine Medication Sales by Application (2017-2028)
7.2.2 Europe Nifedipine Medication Revenue by Application (2017-2028)
7.3 Europe Nifedipine Medication Market Size by Country
7.3.1 Europe Nifedipine Medication Sales by Country (2017-2028)
7.3.2 Europe Nifedipine Medication Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nifedipine Medication Market Size by Type
8.1.1 Asia Pacific Nifedipine Medication Sales by Type (2017-2028)
8.1.2 Asia Pacific Nifedipine Medication Revenue by Type (2017-2028)
8.2 Asia Pacific Nifedipine Medication Market Size by Application
8.2.1 Asia Pacific Nifedipine Medication Sales by Application (2017-2028)
8.2.2 Asia Pacific Nifedipine Medication Revenue by Application (2017-2028)
8.3 Asia Pacific Nifedipine Medication Market Size by Region
8.3.1 Asia Pacific Nifedipine Medication Sales by Region (2017-2028)
8.3.2 Asia Pacific Nifedipine Medication Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Nifedipine Medication Market Size by Type
9.1.1 Latin America Nifedipine Medication Sales by Type (2017-2028)
9.1.2 Latin America Nifedipine Medication Revenue by Type (2017-2028)
9.2 Latin America Nifedipine Medication Market Size by Application
9.2.1 Latin America Nifedipine Medication Sales by Application (2017-2028)
9.2.2 Latin America Nifedipine Medication Revenue by Application (2017-2028)
9.3 Latin America Nifedipine Medication Market Size by Country
9.3.1 Latin America Nifedipine Medication Sales by Country (2017-2028)
9.3.2 Latin America Nifedipine Medication Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Nifedipine Medication Market Size by Type
10.1.1 Middle East and Africa Nifedipine Medication Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nifedipine Medication Revenue by Type (2017-2028)
10.2 Middle East and Africa Nifedipine Medication Market Size by Application
10.2.1 Middle East and Africa Nifedipine Medication Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nifedipine Medication Revenue by Application (2017-2028)
10.3 Middle East and Africa Nifedipine Medication Market Size by Country
10.3.1 Middle East and Africa Nifedipine Medication Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nifedipine Medication Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Elite Pharmaceutical Solution Inc.
11.1.1 Elite Pharmaceutical Solution Inc. Corporation Information
11.1.2 Elite Pharmaceutical Solution Inc. Overview
11.1.3 Elite Pharmaceutical Solution Inc. Nifedipine Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Elite Pharmaceutical Solution Inc. Nifedipine Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Elite Pharmaceutical Solution Inc. Recent Developments
11.2 Pharmaoffer.com
11.2.1 Pharmaoffer.com Corporation Information
11.2.2 Pharmaoffer.com Overview
11.2.3 Pharmaoffer.com Nifedipine Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pharmaoffer.com Nifedipine Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pharmaoffer.com Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan Nifedipine Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mylan Nifedipine Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nifedipine Medication Industry Chain Analysis
12.2 Nifedipine Medication Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nifedipine Medication Production Mode & Process
12.4 Nifedipine Medication Sales and Marketing
12.4.1 Nifedipine Medication Sales Channels
12.4.2 Nifedipine Medication Distributors
12.5 Nifedipine Medication Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nifedipine Medication Industry Trends
13.2 Nifedipine Medication Market Drivers
13.3 Nifedipine Medication Market Challenges
13.4 Nifedipine Medication Market Restraints
14 Key Findings in The Global Nifedipine Medication Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Nifedipine Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Tablet
Table 4. Global Nifedipine Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Nifedipine Medication Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Nifedipine Medication Sales by Region (2017-2022) & (K Units)
Table 7. Global Nifedipine Medication Sales Market Share by Region (2017-2022)
Table 8. Global Nifedipine Medication Sales by Region (2023-2028) & (K Units)
Table 9. Global Nifedipine Medication Sales Market Share by Region (2023-2028)
Table 10. Global Nifedipine Medication Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Nifedipine Medication Revenue Market Share by Region (2017-2022)
Table 12. Global Nifedipine Medication Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Nifedipine Medication Revenue Market Share by Region (2023-2028)
Table 14. Global Nifedipine Medication Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Nifedipine Medication Sales Share by Manufacturers (2017-2022)
Table 16. Global Nifedipine Medication Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Nifedipine Medication Revenue Share by Manufacturers (2017-2022)
Table 18. Nifedipine Medication Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Nifedipine Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Nifedipine Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine Medication as of 2021)
Table 21. Nifedipine Medication Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Nifedipine Medication Product Offered
Table 23. Date of Manufacturers Enter into Nifedipine Medication Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nifedipine Medication Sales by Type (2017-2022) & (K Units)
Table 26. Global Nifedipine Medication Sales by Type (2023-2028) & (K Units)
Table 27. Global Nifedipine Medication Sales Share by Type (2017-2022)
Table 28. Global Nifedipine Medication Sales Share by Type (2023-2028)
Table 29. Global Nifedipine Medication Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Nifedipine Medication Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Nifedipine Medication Revenue Share by Type (2017-2022)
Table 32. Global Nifedipine Medication Revenue Share by Type (2023-2028)
Table 33. Nifedipine Medication Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Nifedipine Medication Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Nifedipine Medication Sales by Application (2017-2022) & (K Units)
Table 36. Global Nifedipine Medication Sales by Application (2023-2028) & (K Units)
Table 37. Global Nifedipine Medication Sales Share by Application (2017-2022)
Table 38. Global Nifedipine Medication Sales Share by Application (2023-2028)
Table 39. Global Nifedipine Medication Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Nifedipine Medication Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Nifedipine Medication Revenue Share by Application (2017-2022)
Table 42. Global Nifedipine Medication Revenue Share by Application (2023-2028)
Table 43. Nifedipine Medication Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Nifedipine Medication Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Nifedipine Medication Sales by Type (2017-2022) & (K Units)
Table 46. North America Nifedipine Medication Sales by Type (2023-2028) & (K Units)
Table 47. North America Nifedipine Medication Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Nifedipine Medication Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Nifedipine Medication Sales by Application (2017-2022) & (K Units)
Table 50. North America Nifedipine Medication Sales by Application (2023-2028) & (K Units)
Table 51. North America Nifedipine Medication Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Nifedipine Medication Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Nifedipine Medication Sales by Country (2017-2022) & (K Units)
Table 54. North America Nifedipine Medication Sales by Country (2023-2028) & (K Units)
Table 55. North America Nifedipine Medication Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Nifedipine Medication Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Nifedipine Medication Sales by Type (2017-2022) & (K Units)
Table 58. Europe Nifedipine Medication Sales by Type (2023-2028) & (K Units)
Table 59. Europe Nifedipine Medication Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Nifedipine Medication Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Nifedipine Medication Sales by Application (2017-2022) & (K Units)
Table 62. Europe Nifedipine Medication Sales by Application (2023-2028) & (K Units)
Table 63. Europe Nifedipine Medication Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Nifedipine Medication Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Nifedipine Medication Sales by Country (2017-2022) & (K Units)
Table 66. Europe Nifedipine Medication Sales by Country (2023-2028) & (K Units)
Table 67. Europe Nifedipine Medication Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Nifedipine Medication Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Nifedipine Medication Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Nifedipine Medication Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Nifedipine Medication Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Nifedipine Medication Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Nifedipine Medication Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Nifedipine Medication Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Nifedipine Medication Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Nifedipine Medication Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Nifedipine Medication Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Nifedipine Medication Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Nifedipine Medication Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Nifedipine Medication Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Nifedipine Medication Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Nifedipine Medication Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Nifedipine Medication Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Nifedipine Medication Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Nifedipine Medication Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Nifedipine Medication Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Nifedipine Medication Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Nifedipine Medication Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Nifedipine Medication Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Nifedipine Medication Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Nifedipine Medication Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Nifedipine Medication Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Nifedipine Medication Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Nifedipine Medication Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Nifedipine Medication Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Nifedipine Medication Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Nifedipine Medication Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Nifedipine Medication Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Nifedipine Medication Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Nifedipine Medication Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Nifedipine Medication Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Nifedipine Medication Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Nifedipine Medication Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Nifedipine Medication Revenue by Country (2023-2028) & (US$ Million)
Table 105. Elite Pharmaceutical Solution Inc. Corporation Information
Table 106. Elite Pharmaceutical Solution Inc. Description and Major Businesses
Table 107. Elite Pharmaceutical Solution Inc. Nifedipine Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Elite Pharmaceutical Solution Inc. Nifedipine Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Elite Pharmaceutical Solution Inc. Recent Developments
Table 110. Pharmaoffer.com Corporation Information
Table 111. Pharmaoffer.com Description and Major Businesses
Table 112. Pharmaoffer.com Nifedipine Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Pharmaoffer.com Nifedipine Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Pharmaoffer.com Recent Developments
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Major Businesses
Table 117. Mylan Nifedipine Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Mylan Nifedipine Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Mylan Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Nifedipine Medication Distributors List
Table 123. Nifedipine Medication Customers List
Table 124. Nifedipine Medication Market Trends
Table 125. Nifedipine Medication Market Drivers
Table 126. Nifedipine Medication Market Challenges
Table 127. Nifedipine Medication Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Nifedipine Medication Product Picture
Figure 3. Global Nifedipine Medication Market Share by Type in 2021 & 2028
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Nifedipine Medication Market Share by Application in 2021 & 2028
Figure 6. Angina
Figure 7. High Blood Pressure
Figure 8. Raynaud's phenomenon
Figure 9. Premature Labor
Figure 10. Nifedipine Medication Report Years Considered
Figure 11. Global Nifedipine Medication Sales 2017-2028 (K Units)
Figure 12. Global Nifedipine Medication Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Nifedipine Medication Revenue 2017-2028 (US$ Million)
Figure 14. Global Nifedipine Medication Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Nifedipine Medication Sales Market Share by Region (2017-2022)
Figure 16. Global Nifedipine Medication Sales Market Share by Region (2023-2028)
Figure 17. North America Nifedipine Medication Sales YoY (2017-2028) & (K Units)
Figure 18. North America Nifedipine Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Nifedipine Medication Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Nifedipine Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Nifedipine Medication Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Nifedipine Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Nifedipine Medication Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Nifedipine Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Nifedipine Medication Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Nifedipine Medication Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Nifedipine Medication Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Nifedipine Medication in the World: Market Share by Nifedipine Medication Revenue in 2021
Figure 29. Global Nifedipine Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Nifedipine Medication Sales Market Share by Type (2017-2028)
Figure 31. Global Nifedipine Medication Revenue Market Share by Type (2017-2028)
Figure 32. Global Nifedipine Medication Sales Market Share by Application (2017-2028)
Figure 33. Global Nifedipine Medication Revenue Market Share by Application (2017-2028)
Figure 34. North America Nifedipine Medication Sales Market Share by Type (2017-2028)
Figure 35. North America Nifedipine Medication Revenue Market Share by Type (2017-2028)
Figure 36. North America Nifedipine Medication Sales Market Share by Application (2017-2028)
Figure 37. North America Nifedipine Medication Revenue Market Share by Application (2017-2028)
Figure 38. North America Nifedipine Medication Sales Share by Country (2017-2028)
Figure 39. North America Nifedipine Medication Revenue Share by Country (2017-2028)
Figure 40. United States Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Nifedipine Medication Sales Market Share by Type (2017-2028)
Figure 43. Europe Nifedipine Medication Revenue Market Share by Type (2017-2028)
Figure 44. Europe Nifedipine Medication Sales Market Share by Application (2017-2028)
Figure 45. Europe Nifedipine Medication Revenue Market Share by Application (2017-2028)
Figure 46. Europe Nifedipine Medication Sales Share by Country (2017-2028)
Figure 47. Europe Nifedipine Medication Revenue Share by Country (2017-2028)
Figure 48. Germany Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 49. France Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Nifedipine Medication Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Nifedipine Medication Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Nifedipine Medication Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Nifedipine Medication Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Nifedipine Medication Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Nifedipine Medication Revenue Share by Region (2017-2028)
Figure 59. China Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 62. India Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Nifedipine Medication Sales Market Share by Type (2017-2028)
Figure 69. Latin America Nifedipine Medication Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Nifedipine Medication Sales Market Share by Application (2017-2028)
Figure 71. Latin America Nifedipine Medication Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Nifedipine Medication Sales Share by Country (2017-2028)
Figure 73. Latin America Nifedipine Medication Revenue Share by Country (2017-2028)
Figure 74. Mexico Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Nifedipine Medication Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Nifedipine Medication Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Nifedipine Medication Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Nifedipine Medication Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Nifedipine Medication Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Nifedipine Medication Revenue Share by Country (2017-2028)
Figure 83. Turkey Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Nifedipine Medication Revenue (2017-2028) & (US$ Million)
Figure 86. Nifedipine Medication Value Chain
Figure 87. Nifedipine Medication Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed


★調査レポート[ニフェジピン薬の世界市場インサイト・予測（～2028年）] (コード：QY22JLX10428)販売に関する免責事項を必ずご確認ください。
★調査レポート[ニフェジピン薬の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 水虫薬の世界市場インサイト・予測（～2028年）
  • 多回投与薬カートの世界市場インサイト・予測（～2028年）
  • 単位投与用投薬カートの世界市場インサイト・予測（～2028年）
  • スマート薬物吸入器の世界市場インサイト・予測（～2028年）
  • スマート薬剤分配器の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆